BioArctic AB (BRCTF)
31.78
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
BioArctic Debt to Equity Ratio : 0.0185 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0185 |
| December 31, 2025 | 0.0224 |
| September 30, 2025 | 0.0236 |
| June 30, 2025 | 0.0241 |
| March 31, 2025 | 0.0264 |
| December 31, 2024 | 0.0606 |
| September 30, 2024 | 0.0614 |
| June 30, 2024 | 0.0642 |
| March 31, 2024 | 0.0044 |
| December 31, 2023 | 0.0048 |
| September 30, 2023 | 0.0027 |
| June 30, 2023 | 0.0062 |
| March 31, 2023 | 0.0073 |
| December 31, 2022 | 0.0128 |
| September 30, 2022 | 0.0121 |
| June 30, 2022 | 0.0174 |
| March 31, 2022 | 0.019 |
| December 31, 2021 | 0.0201 |
| September 30, 2021 | 0.0221 |
| June 30, 2021 | 0.0228 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.0221 |
| December 31, 2020 | 0.0229 |
| September 30, 2020 | 0.0239 |
| June 30, 2020 | 0.0244 |
| March 31, 2020 | 0.0251 |
| December 31, 2019 | 0.0281 |
| September 30, 2019 | 0.0287 |
| June 30, 2019 | 0.03 |
| March 31, 2019 | 0.0305 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Hansa Biopharma AB | -1.987 |
| Swedish Orphan Biovitrum AB | 0.4162 |
| Diamyd Medical AB | 0.2051 |
| BONESUPPORT HOLDING AB | 0.0107 |
| BioInvent International AB | 0.0142 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 281.25M |
| Total Liabilities (Quarterly) | 50.51M |
| Shareholders Equity (Quarterly) | 230.74M |
| Current Ratio | 6.538 |
| Net Debt Paydown Yield | 0.00% |